※ 출처: ClinicalTrials.gov
총 245건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B HIV Infection|Hepatitis B Biological: HEPLISAV-B|Biological: ENGERIX-B National Institute of Allergy and Infectious Diseases (NIAID)|Dynavax Technologies Corporation Phase 3 2020-08-07
2 A Study of Nivolumab Plus NKTR-214 vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That Has Invaded the Muscle Wall of the Bladder and Who Cannot Get Cisplatin, a Type of Medicine Given to Treat Bladder Cancer. Bladder Cancer|Bladder Tumor|Muscle-Invasive Bladder Cancer Biological: Nivolumab|Biological: NKTR-214|Procedure: Radical cystectomy (RC) Bristol-Myers Squibb|Nektar Therapeutics Phase 3 2020-01-23
3 A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation Carcinoma, Hepatocellular Drug: Atezolizumab|Drug: Bevacizumab Hoffmann-La Roche Phase 3 2019-12-31
4 A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) Bladder Cancer Drug: nivolumab|Other: Placebo|Biological: Bacillus Calmette-Guérin (BCG) Bristol-Myers Squibb Phase 3 2019-12-09
5 A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Prostate Cancer Biological: nivolumab|Drug: prednisone|Drug: docetaxel Bristol-Myers Squibb Phase 3 2019-12-06
6 A Study to Evaluate Efficacy and Safety of Upadacitinib in Adult Participants With Axial Spondyloarthritis Spondyloarthritis Drug: Upadacitinib|Drug: Placebo AbbVie Phase 3 2019-11-26
7 A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV), Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals Healthy Biological: Ad26.Mos4.HIV|Biological: Clade C and Mosaic gp140 HIV bivalent vaccine|Biological: Placebo Janssen Vaccines & Prevention B.V. Phase 3 2019-10-31
8 Study of Nivolumab Versus Placebo in Participants With High-Risk Breast Cancer Breast Cancer Biological: nivolumab|Drug: paclitaxel (PTX)|Other: nivolumab placebo|Drug: anthracycline|Drug: cyclophosphamide|Drug: Endocrine Therapy|Procedure: Surgery Bristol-Myers Squibb Phase 3 2019-10-25
9 A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung Biological: Nivolumab|Drug: Carboplatin|Drug: Cisplatin|Drug: Paclitaxel|Drug: Pemetrexed|Drug: Placebo|Drug: Docetaxel Bristol-Myers Squibb Phase 3 2019-09-16
10 Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations Chronic Obstructive Pulmonary Disease Biological: Benralizumab|Biological: Placebo AstraZeneca Phase 3 2019-08-26